| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-05 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |